ICD-10-CM Billable Code

N60.9

Unspecified benign mammary dysplasia

Clinical Classification Guidelines

Medical Intelligence & Overview

Unspecified benign mammary dysplasia is a common breast condition characterized by non-cancerous changes in breast tissue. Often identified during routine examinations or imaging tests, this condition is generally benign, meaning it does not pose a threat of cancer. Despite its benign nature, understanding this condition can help women better comprehend their breast health and the importance of monitoring any changes. The term 'unspecified' indicates that the exact type or cause of the dysplasia has not been classified specifically, but the diagnosis confirms that the changes are benign.

Causes & Symptoms

Clinical Causes: Hormonal fluctuations during menstrual cycles, pregnancy, or menopause Genetic predisposition to breast tissue changes Lifestyle factors such as diet, alcohol consumption, or smoking History of breast trauma or injury Use of certain medications that influence hormone levels

Key Symptoms: Lumps or thickening in the breast tissue Breast pain or tenderness, especially before menstruation Changes in the texture or appearance of the breast skin Swelling or a feeling of fullness in the breasts Nipple discharge that is not related to breast cancer

Diagnostic & Treatment

Diagnosis Path: • Clinical assessment: Your healthcare provider will review your medical history and examine your breasts for any palpable abnormalities.

Treatment Protocols: • Surgical intervention: Rarely needed, but may be considered if a lump is persistent or causes significant discomfort.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is N60.9 a billable ICD-10 code?
Yes, N60.9 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report N60.9?
Clinical documentation must specify the nature of Unspecified benign mammary dysplasia and any associated comorbidities for accurate reporting.

Cite this Clinical Reference